Natural Product Based Antibody Drug Conjugates: Clinical Status as of November 9, 2020
- 26 February 2021
- journal article
- review article
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 84 (3) , 917-931
Abstract
As of early November 2020, there are 10 approved antibody drug conjugates (ADCs) plus two others that are not usually listed. In addition, there are 70 ADCs at stages from phase I to phase III and 23 that are at the preclinical stage. The warheads of all of these drugs and drug candidates have their origins in natural product structures. The sources and modifications are discussed in general and then specifically commented on in each case with either the generic name if known and/or the ADC’s ID names. Interestingly, almost all warheads listed are from microbial sources though initially a number were thought to have been from plants. The latest NCT numbers from Clintrials.gov of all phase I to phase III candidates are also given. Three unusual ADCs are also discussed, two of which (an antitumor agent and one directed against autoimmune diseases) are not usually listed as ADCs, with the third being an anti-infective.Keywords
This publication has 57 references indexed in Scilit:
- Interactions between Co-Habitating fungi Elicit Synthesis of Taxol from an Endophytic Fungus in Host Taxus PlantsFrontiers in Microbiology, 2013
- Antibody Fusion Proteins: Anti-CD22 Recombinant Immunotoxin Moxetumomab PasudotoxClinical Cancer Research, 2011
- Antineoplastic Agents. 592. Highly Effective Cancer Cell Growth Inhibitory Structural Modifications of Dolastatin 10Journal of Natural Products, 2011
- Tubulin-based antimitotic mechanism of E7974, a novel analogue of the marine sponge natural product hemiasterlinMolecular Cancer Therapeutics, 2009
- Drug-conjugated monoclonal antibodies for the treatment of cancerCurrent Opinion in Pharmacology, 2005
- Symplostatin 1: A Dolastatin 10 Analogue from the Marine Cyanobacterium Symploca hydnoidesJournal of Natural Products, 1998
- Total synthesis of anthramycinJournal of the American Chemical Society, 1968
- The Structure of AnthramycinJournal of the American Chemical Society, 1965
- Isolation and Characterization of Anthramycin, a New Antitumor AntibioticJournal of the American Chemical Society, 1965
- Address in Pathology, ON CHEMIOTHERAPY: Delivered before the Seventeenth International Congress of MedicineBMJ, 1913